Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Beckman Coulter to acquire diagnostic systems business from Olympus
As part of the agreement, Beckman Coulter has the right to deliver up to 37.5% of the purchase price in the form of Beckman Coulter stock. Correspondingly, Beckman
As part of the agreement, Beckman Coulter has the right to deliver up to 37.5% of the purchase price in the form of Beckman Coulter stock. Correspondingly, Beckman
The experimental work has been performed in collaboration with Christophe Baudouin from the Quinze-Vingts National Ophthalmology Hospital and Science Faculty of Paris V, France. According to the company,
The company has entered into a purchase agreement with certain affiliated funds of Special Situations Funds to raise $2 million from the private placement of two million newly
Initial findings from the ongoing open-label, multi-center study demonstrates that AT-101 can be administered safely with docetaxel and prednisone (D/P) in these patients. Investigators also observed clinical responses,
Prior to being named COO, Mr Casper served as president of Thermo Fisher’s analytical technologies businesses following the merger of Thermo Electron and Fisher Scientific in 2006. Mr
The Navistar RMT Thermocool catheter is used with Stereotaxis’s Niobe remote magnetic navigation system for mapping and radiofrequency ablation to treat irregular heartbeats, or cardiac arrhythmias. Stereotaxis expects
The classification and industry position allows for a significant increase in profit margins and scalability of manufacturing operations, the company said. This license completes Sohm’s infrastructure development for
The new facility is well equipped with PerkinElmer instruments, software and reagents for biotech, pharmaceutical and academic customers that enable scientific workshops, demonstrations and customer support and training.
The product will be made commercially available immediately, said Genzyme. Myozyme is reported to be the only approved treatment for Pompe disease, a progressively debilitating and often fatal
The two new patents cover isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, human resistin and human syntaxin binding protein 2, vectors and hosts containing these